STREAMEX CORP. (STEX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseSTEX / S&P -24.78% / 15.20% |
LoseSTEX / S&P STEX unavailable / 15.00% |
WinSTEX / S&P 778.64% / 50.40% |
| 2026-Q11/3 |
LoseSTEX / S&P -62.71% / -4.33% |
LoseSTEX / S&P STEX unavailable / 11.30% |
WinSTEX / S&P 1545.76% / 27.70% |
| 2025-Q41/3 |
LoseSTEX / S&P -47.40% / 2.65% |
LoseSTEX / S&P STEX unavailable / 9.00% |
WinSTEX / S&P 1082.72% / 13.40% |
| 2025-Q30/3 |
LoseSTEX / S&P -19.33% / 8.12% |
LoseSTEX / S&P STEX unavailable / 4.61% |
LoseSTEX / S&P -1.43% / 13.45% |
| 2025-Q21/3 |
WinSTEX / S&P 1088.02% / 10.94% |
LoseSTEX / S&P STEX unavailable / 4.83% |
LoseSTEX / S&P -45.50% / 10.63% |
| 2025-Q10/3 |
LoseSTEX / S&P -59.66% / -4.27% |
LoseSTEX / S&P STEX unavailable / 4.98% |
LoseSTEX / S&P -81.39% / 10.57% |
| 2024-Q41/3 |
WinSTEX / S&P 338.24% / 2.41% |
LoseSTEX / S&P STEX unavailable / 5.25% |
LoseSTEX / S&P -79.75% / 6.15% |
| 2024-Q30/3 |
LoseSTEX / S&P -2.86% / 5.89% |
LoseSTEX / S&P STEX unavailable / 5.89% |
LoseSTEX / S&P -84.80% / 6.11% |
| 2024-Q20/3 |
LoseSTEX / S&P -47.05% / 4.28% |
LoseSTEX / S&P -85.45% / 5.38% |
LoseSTEX / S&P -78.38% / 5.12% |
| 2024-Q10/3 |
LoseSTEX / S&P -86.08% / 10.56% |
LoseSTEX / S&P -90.46% / 5.71% |
LoseSTEX / S&P STEX unavailable / 5.59% |
| 2023-Q40/3 |
LoseSTEX / S&P -2.86% / 11.69% |
LoseSTEX / S&P -93.71% / 6.81% |
LoseSTEX / S&P STEX unavailable / 7.78% |
| 2023-Q30/3 |
LoseSTEX / S&P -60.88% / -3.27% |
LoseSTEX / S&P -11.32% / 7.52% |
LoseSTEX / S&P STEX unavailable / -5.03% |
| 2023-Q22/3 |
WinSTEX / S&P 9.65% / 8.74% |
WinSTEX / S&P 108.33% / 9.50% |
LoseSTEX / S&P STEX unavailable / -8.57% |
| 2023-Q11/3 |
WinSTEX / S&P 171.43% / 7.50% |
LoseSTEX / S&P -14.50% / 10.77% |
LoseSTEX / S&P STEX unavailable / -15.69% |
| 2022-Q40/3 |
LoseSTEX / S&P -34.38% / 7.56% |
LoseSTEX / S&P -35.15% / 11.88% |
LoseSTEX / S&P STEX unavailable / -17.99% |
| 2022-Q31/3 |
WinSTEX / S&P -2.74% / -4.88% |
LoseSTEX / S&P -63.28% / 13.47% |
LoseSTEX / S&P STEX unavailable / -1.41% |
| 2022-Q20/3 |
LoseSTEX / S&P -42.78% / -16.10% |
LoseSTEX / S&P -59.38% / 13.71% |
LoseSTEX / S&P STEX unavailable / 11.04% |
| 2022-Q11/3 |
LoseSTEX / S&P -48.43% / -4.60% |
WinSTEX / S&P 180.51% / 15.97% |
LoseSTEX / S&P STEX unavailable / 42.23% |
| 2021-Q40/3 |
LoseSTEX / S&P -25.17% / 11.03% |
LoseSTEX / S&P STEX unavailable / 15.00% |
LoseSTEX / S&P STEX unavailable / 96.40% |
| 2021-Q30/3 |
LoseSTEX / S&P -22.80% / 0.58% |
LoseSTEX / S&P STEX unavailable / 10.77% |
LoseSTEX / S&P STEX unavailable / 69.42% |
| 2021-Q20/3 |
LoseSTEX / S&P -10.44% / 8.55% |
LoseSTEX / S&P STEX unavailable / 6.58% |
LoseSTEX / S&P STEX unavailable / 51.81% |
| 2021-Q11/3 |
WinSTEX / S&P 10.51% / 6.17% |
LoseSTEX / S&P STEX unavailable / -1.06% |
LoseSTEX / S&P STEX unavailable / 7.39% |
| 2020-Q40/3 |
LoseSTEX / S&P -20.89% / 12.15% |
LoseSTEX / S&P STEX unavailable / -3.72% |
LoseSTEX / S&P STEX unavailable / -33.42% |
| 2020-Q30/3 |
LoseSTEX / S&P -31.53% / 8.93% |
LoseSTEX / S&P STEX unavailable / -2.04% |
LoseSTEX / S&P STEX unavailable / -27.10% |
| 2020-Q21/3 |
WinSTEX / S&P 71.84% / 20.54% |
LoseSTEX / S&P STEX unavailable / -0.46% |
LoseSTEX / S&P STEX unavailable / -27.11% |
| 2020-Q10/3 |
LoseSTEX / S&P -29.22% / -19.60% |
LoseSTEX / S&P STEX unavailable / 3.47% |
LoseSTEX / S&P STEX unavailable / -14.75% |
| 2019-Q40/3 |
LoseSTEX / S&P -28.24% / 9.07% |
LoseSTEX / S&P STEX unavailable / 5.36% |
LoseSTEX / S&P STEX unavailable / 2.99% |
| 2019-Q30/3 |
LoseSTEX / S&P -12.14% / 1.70% |
LoseSTEX / S&P STEX unavailable / 5.02% |
LoseSTEX / S&P STEX unavailable / 0.21% |
| 2019-Q21/3 |
WinSTEX / S&P 52.93% / 4.30% |
LoseSTEX / S&P STEX unavailable / 6.64% |
LoseSTEX / S&P STEX unavailable / 8.65% |
| 2019-Q11/3 |
WinSTEX / S&P 43.79% / 13.65% |
LoseSTEX / S&P STEX unavailable / 8.12% |
LoseSTEX / S&P STEX unavailable / 14.29% |
| 2018-Q40/3 |
LoseSTEX / S&P -23.48% / -13.52% |
LoseSTEX / S&P STEX unavailable / 9.05% |
LoseSTEX / S&P STEX unavailable / 18.23% |
| 2018-Q30/3 |
LoseSTEX / S&P -5.82% / 7.71% |
LoseSTEX / S&P STEX unavailable / 10.21% |
LoseSTEX / S&P STEX unavailable / 19.06% |
| 2018-Q21/3 |
WinSTEX / S&P 50.96% / 3.43% |
LoseSTEX / S&P STEX unavailable / 9.03% |
LoseSTEX / S&P STEX unavailable / 14.46% |
| 2018-Q11/3 |
WinSTEX / S&P 9.03% / -0.76% |
LoseSTEX / S&P STEX unavailable / 7.68% |
LoseSTEX / S&P STEX unavailable / 12.46% |
| 2017-Q40/3 |
LoseSTEX / S&P 5.88% / 6.64% |
LoseSTEX / S&P STEX unavailable / 7.03% |
LoseSTEX / S&P STEX unavailable / 13.82% |
| 2017-Q30/3 |
LoseSTEX / S&P -7.48% / 4.48% |
LoseSTEX / S&P STEX unavailable / 5.68% |
LoseSTEX / S&P STEX unavailable / 17.57% |
| 2017-Q20/3 |
LoseSTEX / S&P 1.38% / 3.09% |
LoseSTEX / S&P STEX unavailable / 4.83% |
LoseSTEX / S&P STEX unavailable / 17.74% |
| 2017-Q11/3 |
WinSTEX / S&P 12.40% / 6.07% |
LoseSTEX / S&P STEX unavailable / 3.67% |
LoseSTEX / S&P STEX unavailable / 13.32% |
| 2016-Q40/3 |
LoseSTEX / S&P -15.13% / 3.82% |
LoseSTEX / S&P STEX unavailable / 2.09% |
LoseSTEX / S&P STEX unavailable / 7.05% |
| 2016-Q30/3 |
LoseSTEX / S&P -0.65% / 3.85% |
LoseSTEX / S&P STEX unavailable / 0.20% |
LoseSTEX / S&P STEX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | STEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -82.70% | 20.78% |
| Annualized return | -82.70% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | STEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.31% | 83.14% |
| Annualized return | -51.49% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | STEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.79% | 319.30% |
| Annualized return | -31.71% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |